InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Bornstein Jeffrey S, Director. Director active across 1 companies, notably Allovir, Inc.. In total, 3 disclosures have been recorded. Total volume traded: €99k. The latest transaction was disclosed on 26 April 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
€21,7945,000 shares@ €4.358821.9% of flow
Common Stock
SEC:0000899243-22-015826:0·
Ideal exit: 21 Jan 2023 (T+270)
€38,8305,000 shares@ €7.766100.0% of flow
Common Stock
SEC:0000899243-22-005623·
Ideal exit: 7 Nov 2022 (T+270)
€38,8305,000 shares@ €7.76639.0% of flow
Common Stock
SEC:0000899243-22-005623:0·
Ideal exit: 7 Nov 2022 (T+270)
3 of 3 declarations
About Bornstein Jeffrey S
Jeffrey S. Bornstein is a Director at Allovir, Inc. He contributes to the governance and oversight of the company's activities, bringing his expertise in the biopharmaceutical sector. His role is essential in guiding strategic decisions.
